A video on Chandra Theegala's patented oil-water separator technology. The separator may be used to separate oil from water in situ in the ocean or other water body. This is a patented technology (Patent Number: 9,284,705).
Researchers at the LSU AgCenter are developing a technology that could
potentially use a Nanoparticle Matrix to treat cataracts. If successful,
it would first be used to treat animals with these eye problems, with
the hope it could then be used for human treatments. This is a patent pending technology (PCT/US2015/044483).
This is a new method of producing though and flexible thermoset polymers from recycled sugarcane biomass that are potentially biodegradable.
This is a method to form water soluble high milecuar weight chitosan products with high chitosan concentrations.
This is a nanoparticle delivery system that seeks to deliver natural antioxidants, such as lutein, to the eye for treatment of eye diseases like cataracts.
A poster on LSU AgCenter's magnetic biochar that can remove and reuse phosphates from soil.
This invention is a new class of nano-micelles that can treat various forms of cancer. The nano-micelles work by restoring mutated cells and regulating their growth.
LSU AgCenter scientists have developed a new infill material for artificial turfgrass. The product is made from a low-cost recycled material blend that reduces potential infill side effects, is better for the environment, and still looks great for recreational or sports use.
VECAR protects cells from oxidation and can drive useful prodrugs to the artery wall to decrease plaque formation. Preventing plaque buildup reduces the chances of blood clots, which can lead to heart attacks and strokes. This invention is a new antioxidant molecule composed of vitamin E and carnosine (VECAR) that provides multiple layers of protection. This is a patented technology (Patent Number: 9,220,787).
This is a new formulation for paclitaxel which utilizes natural plant derivatives to increase the solubility and permeability of paclitaxel to allow for oral administration. Cellular studies showed the permeability of paclitaxel increased tenfold to 20 cm/s.